CLBX — Cellbxhealth Share News
0.000.00%
Last trade - 00:00- £9.40m
- £7.84m
- £1.35m
Exclusive agreement for DNA NGS panel
Brief: Angle Plc In Agreement With Recursion Pharma
Agreement with Recursion Pharmaceuticals
Notice of Interim Results and Webcast
Data supporting FDA approval published in Journal
Independent Parsortix study
Standard form for notification of major holdings
Standard form for notification of major holdings
Brief: Angle Raises 9.3 Mln Stg Pursuant To Placing, Subscription & Open Offer
Result of open offer
Posting of 2023 Annual Report & Notice of the AGM
Parsortix and assays being showcased at EACR 2024
Results of placing and subscription
Brief: Angle Announces 8.5 Mln Stg Fundraising
Proposed Placing, Subscription and Open Offer
Preliminary Results
Study of ovarian cancer CTCs using Parsortix
New commercial agreement with large pharma
Brief: Angle Signs New Commercial Agreement With Astrazeneca